All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-ENTPD5 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-0001-FY | CBFYE-0291 | Mouse | Human | IgG2b | Recombinant corresponding to aa21-428 from human ENTPD5 expressed in CHO cell line | |
DMAb-0232-FY | EPR3784 | Rabbit | Human | IgG | A synthetic peptide corresponding to residues in human ENTPD5 was used as an immunogen | |
DMAb-0233-FY | CBFYE-0223 | Mouse | Human | IgG2b | Partial recombinant corresponding to aa319-400 from human ENTPD5 with GST tag. MW of the GST tag alone is 26kD. | |
DMAb-0234-FY | CBFYE-0909 | Mouse | Human | IgG1 | Recombinant human ENTPD5 protein | |
DMAb-0235-FY | CBFYE-0910 | Mouse | Human | IgG2b | Recombinant corresponding to AA 21-428 from human ENTPD5 expressed in CHO cell line. Immunogen type: Recombinant protein. | |
DMAb-0236-FY | CBFYE-0911 | Rabbit | Human | IgG | Recombinant Human ENTPD5 protein | |
DMAb-0773-CQ | CBXC-1310 | Mouse | IgG2b | CHO-derived recombinant human CD39L4/ENTPD5, Val21-His428, Accession # O75356 |
There are currently no customer reviews or questions for Anti-ENTPD5 DNA-encoded mAb (DMAb), pVAX1 (DMAb-0001-FY). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION